The study will test whether a medication called tranexamic acid can help reduce the amount of blood lost during hip surgery in children. Some patients will receive tranexamic acid through an injection into their vein, while others will receive a placebo with saline solution. The medication or placebo will be given before the surgery starts.

The surgical procedures involved in this study are proximal femoral osteotomy and pelvic osteotomy, which are operations where surgeons make controlled cuts in the hip bones to improve their position and function. During the study, doctors will measure how much blood is lost during surgery and monitor the patients’ recovery. This will help determine if tranexamic acid is effective in reducing blood loss during these types of hip surgeries in children.

The main goal of the study is to find out if Tranexamic Acid Oral Solution 5% can effectively reduce bleeding that is significant enough to be considered clinically important. This includes bleeding in the mouth and face area after having teeth extracted. Participants in the study will be randomly assigned to receive either the tranexamic acid solution or a placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual treatment or the placebo, to ensure unbiased results.

Throughout the study, participants will be monitored for any bleeding episodes after their dental procedures. The study will also assess how acceptable the medication is to the participants, which means looking at how easy it is for them to take the medication as directed. The study is expected to last for a short period, with the treatment being given for up to seven days. The results will help determine if Tranexamic Acid Oral Solution 5% is a safe and effective option for managing bleeding in patients on blood thinners undergoing tooth extractions.